Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total

Salvatore Brugaletta1, Josep Gomez-Lara2, Juan Caballero3

  • 1Cardiovascular Institute, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

American Heart Journal
|August 29, 2018
PubMed

Insights

Ticagrelor may improve coronary blood flow after chronic total occlusion (CTO) percutaneous coronary intervention (PCI). This study compared ticagrelor

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Pharmacology

Background:

  • Chronic total occlusions (CTOs) often exhibit impaired coronary vascular function post-recanalization.
  • Percutaneous coronary intervention (PCI) aims to restore blood flow but immediate functional recovery can be limited.
  • Adenosine is used to assess coronary blood flow, a key indicator of vascular health.

Discussion:

  • This research investigates the potential of ticagrelor to enhance adenosine-induced coronary blood flow compared to clopidogrel.
  • The study focuses on the immediate post-successful CTO PCI period.
  • Evaluating P2Y12 inhibitors' impact on microvascular function after CTO recanalization is crucial.

Key Insights:

  • Ticagrelor demonstrated a potential to augment coronary blood flow post-CTO PCI.
  • The study provides immediate functional data comparing ticagrelor and clopidogrel.
  • Findings suggest a possible role for ticagrelor in improving early vascular recovery.

Outlook:

  • Further research could explore long-term functional outcomes and clinical benefits.
  • Investigating optimal antiplatelet strategies post-CTO PCI is warranted.
  • Exploring the mechanisms behind ticagrelor's effect on coronary microvasculature is a future direction.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Ecological Succession02:17

Ecological Succession

Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.5K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
436
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
385